Polsinelli PC is an AmLaw 100 firm with more than 800 attorneys in 20 offices. Ranked 24th for client service excellence (BTI Client Service A-Team 2018) and 10th for best client relationships (BTI Industry Power Rankings 2017) among 650 US law firms, Polsinelli was also named among the top 20 best-known firms in the country (BTI Brand Elite 2017). The firm’s attorneys provide value through practical legal counsel infused with business insight and specialise in healthcare, financial services, real estate, IP, mid-market corporate, business and labour and employment litigation.
The Polsinelli IP practice is a cross-functional group of attorneys organised to serve clients’ IP needs in a variety of industries. Firm attorneys handle the most complex issues facing technology and high-tech companies, bioscience and life sciences companies, animal science, medical device, pharmaceutical, chemical, software and business methods, data, privacy, healthcare, IT and a variety of other high-tech industries.
Polsinelli has one of the largest IP practices in the United States, with a deep bench of attorneys, patent agents and scientists dedicated to helping clients solve their most complex issues relating to the establishment and protection of their intellectual property. In addition to national rankings for patent and trademark law, the firm was recently named a powerhouse in IP litigation – one of only four firms in the United States – based on interviews with general counsel at companies with more than $1 billion in revenue (BTI Litigation Outlook 2016).
Polsinelli’s areas of focus include:
- freedom to operate, patentability, non-infringement and invalidity opinions;
- Hatch-Waxman litigation;
- IP and technology litigation;
- IP counselling and opinions;
- internet and software business assets;
- licensing and technology transactions;
- Patent litigation
- patent prosecution;
- post-grant proceedings;
- trade secrets litigation;
- trademarks and copyrights; and
- trademark and copyright litigation.
Polsinelli’s attorneys counsel Fortune 500 companies, medium-sized public and private companies, start-ups, universities and non-profit research institutes on the versatile challenges faced by these clients. The firm partners with clients to ensure their ideas are adequately protected and its lawyers gain a comprehensive understanding of clients’ businesses so that IP services work in conjunction with their business focus, ensuring the best possible outcome.
Polsinelli assists clients in developing IP strategies, launching websites, raising capital, acquiring and selling technologies and companies, and developing strategic partnerships. Our attorneys review and prepare a wide range of technology, vendor and licensing agreements, as well as protect clients’ assets through trademarks, copyrights, patents, licensing agreements, privacy policies, litigation, technology development agreements and trade secret protection.
Polsinelli’s IP attorneys are supported by a team of patent agents and scientists with impressive qualifications that include PhDs in pharmacology, molecular microbiology and integrative biology and work experience that includes a faculty position in a university’s biology department, a consultant for pharmaceutical and biotechnology companies and a position at the National Institute of Standards and Technology.
Patent litigation practice
Polsinelli’s patent litigators appear in the most active jurisdictions throughout the United States, including the District of Delaware, the Eastern District of Texas, the Northern District of California, the Northern District of Illinois, the Southern District of New York and the International Trade Commission.
Collectively, the firm’s litigators have decades of experience in patent litigation and have been involved in hundreds of patent cases. This experience includes work in every phase of patent litigation, from pre-suit analysis to initial pleadings, claim construction hearings, summary judgment motions, jury trials and appeals.
Polsinelli’s attorneys have been involved in virtually every conceivable technological area, including representing pharmaceutical companies in the highly specialised area of Hatch-Waxman litigation. Our attorneys collaborate with experienced patent prosecutors and scientists that have expertise in the applicable technology.
Specific experience includes cases involving:
- Paragraph IV disputes under the Hatch-Waxman Act;
- chemical processes;
- animal health sciences;
- nutritional supplements;
- software and information technology;
- medical devices;
- electrical and mechanical devices;
- business methods; and
- design patents.
No matter the industry or technology, Polsinelli’s IP group uses its knowledge and experience to provide innovative representation to its clients through the litigation process or alternative dispute resolution.
150 N Riverside Plaza
Chicago IL 60606
- Kansas City
- Los Angeles
- New York
- San Francisco
- Washington DC